A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

Name: A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir
Published: 2017
License: Public Domain

GlaxoSmithKline · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

capsule healthy hiv-infections human-immunodeficiency-virus infection safety

infection, human immunodeficiency virus, hiv infections, gsk2838232, safety, food effect, capsule, healthy, pk, tablet, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

Related documents